Abstract:Background: In asthma remodeling airway smooth muscle cells (ASMCs) contribute to airway wall thickness through increased proliferation, migration, and extracellular matrix deposition. Previously, we described that protein arginine methyltransferase 1 (PRMT1) participates in airway remodeling in pulmonary inflammation in E3 rats.Objective: We sought to define the asthma-specific regulatory mechanism of PRMT1 in human ASMCs.Methods: ASMCs from healthy subjects and asthmatic patients were activated with platelet-derived growth factor (PDGF)-BB. PRMT1 was localized by means of immunohistochemistry in human lung tissue sections and by means of immunofluorescence in isolated ASMCs. PRMT1 activity was suppressed by the pan-PRMT inhibitor AMI-1, signal transducer and activator of transcription 1 (STAT1) was suppressed by small interfering RNA, and extracellular signal-regulated kinase (ERK) 1/2 mitogen-activated protein kinase (MAPK) was suppressed by PD98059. MicroRNAs (miRs) were assessed by using real-time quantitative PCR and regulated by miR mimics or inhibitors.Results: PRMT1 expression was significantly increased in lung tissue sections and in isolated ASMCs of patients with severe asthma. PDGF-BB significantly increased PRMT1 expression through ERK1/2 MAPK and STAT1 signaling in control ASMCs, whereas in ASMCs from asthmatic patients, these proteins were constitutively expressed. ASMCs from asthmatic patients had reduced miR-19a expression, causing upregulation of ERK1/2 MAPK, STAT1, and PRMT1. Inhibition of PRMT1 abrogated collagen type I and fibronectin deposition, cell proliferation, and migration of ASMCs from asthmatic patients.Conclusions: PRMT1 is a central regulator of tissue remodeling in ASMCs from asthmatic patients through the pathway: PDGF-BB-miR-19a-ERK1/2 MAPK and STAT1. Low miR-19a expression in ASMCs from asthmatic patients is the key event that results in constitutive increased PRMT1 expression and remodeling. Therefore PRMT1 is an attractive target to limit airway wall remodeling in asthmatic patients.

Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

Mir-192 Mediates TGF-beta/Smad3-driven Renal Fibrosis.

Inactivation of PRMT1 inhibits cardiac fibrosis via transcriptional regulation and perturbation of FBL activity in fibroblast-to-myofibroblast transition

Smad7 Inhibits Fibrotic Effect of TGF- on Renal Tubular Epithelial Cells by Blocking Smad2 Activation

Regulation of Renal Fibrosis by Smad3 Thr388 Phosphorylation

Activation Of Sirtuin-1 Promotes Renal Fibroblast Activation And Aggravates Renal Fibrogenesis

Smad2 Protects Against TGF-β/Smad3-Mediated Renal Fibrosis

Protein arginine methyltransferases in renal development, injury, repair, and fibrosis.

MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1

Src Kinase Mediates Renal Interstitial Fibroblast Activation and Proliferation

NMDA Receptor-mediated CaMKII/ERK Activation Contributes to Renal Fibrosis

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

Constitutive High Expression of Protein Arginine Methyltransferase 1 in Asthmatic Airway Smooth Muscle Cells is Caused by Reduced Microrna-19A Expression and Leads to Enhanced Remodeling

Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis

Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression.

Smad3 Signaling Activates Bone Marrow-Derived Fibroblasts in Renal Fibrosis

PRDM16 Deficiency Triggered by TGF-β Signaling Aggravated Renal Fibrosis by Promoting Tubular Mitochondrial Dysfunction

TSLP/TSLPR promotes renal fibrosis by activating STAT3 in renal fibroblasts

PDGF-BB Induces PRMT1 Expression Through ERK1/2 Dependent STAT1 Activation and Regulates Remodeling in Primary Human Lung Fibroblasts

Adriamycin induces cardiac fibrosis in mice via PRMT5-mediated cardiac fibroblast activation